Hints and tips:
...But manufacturing and regulatory delays meant Novavax received the green light long after many countries had attempted a return to normality....
...Mounjaro, a similar medication already marketed by Lilly for treating diabetes but which is expected to get a green light from regulators for obesity, is also scarce at least in part because of off-label...
...Albert Bourla, chief executive of Pfizer, said the agility of BioNTech/Pfizer’s mRNA platform and their extensive clinical experience with Covid vaccines had enabled the companies to develop, test and manufacture...
...Their recommendations will then inform whether the Food and Drug Administration gives the green light.If the US regulator does authorise one or both vaccines, thedevelopers say they are ready to start shipping...
...Last week, a panel of external experts at the FDA voted narrowly in favour of giving the green light to Merck’s drug by a margin of 13 to 10....
...The green bond market “potentially has a big role to play” in financing the transition for cities, HSBC wrote....
...Tishman Speyer, one of New York’s largest commercial property developers, had previously secured pharmaceuticals company Pfizer as its anchor tenant for the Spiral....
...Rivals AstraZeneca, Johnson & Johnson, Russia’s Sputnik V and new entrants such as Novavax make up the remainder of the market, which is forecast to double in value to $124bn next year....
...green light that jab for younger children....
...The FDA declined to comment on Pfizer’s application....
...The US Food and Drug Administration on Wednesday gave the green light to mix-and-match boosting, allowing any US citizen at high risk of contracting Covid to receive a further shot of any approved vaccine...
...Pfizer’s pill blocks an enzyme that coronavirus needs to replicate....
...Pfizer noted that the Israeli data was “preliminary and yet to be fully assessed”....
...The decision comes a month after the FDA did the same for the BioNTech/Pfizer vaccine.The regulator added that people will be allowed to receive any of the three authorised shots, regardless of which they...
...The technology-heavy Nasdaq Composite index briefly fell 4.9 per cent before rebounding to end the day in the green....
...Israel may even bring back the “green pass”, which allowed greater freedom for vaccinated people....
...The FDA and Pfizer declined to comment....
...Merck said it would apply for emergency use authorisation for the drug in the US within the next two weeks and seek a green light in several other countries....
...The first fully-fledged approval of a Covid vaccine this week by the US Food and Drug Administration, which gave a green light to the BioNTech/Pfizer jab, has prompted a string of companies to introduce...
...Last month, Pfizer said it planned to apply for approval of its third dose in August....
...“To Pfizer!” she exclaimed, and rushed off to find a table for the crowds pouring through the streets of a neighbourhood in the south of the city on a weekday night. “L’chaim.”...
...The AU will pay $6.75 a dose for the BioNTech/Pfizer vaccine and $10 for Johnson & Johnson’s, a single-dose product....
...Of those received, 5.7m were the BioNTech/Pfizer jab; 3.6m were AstraZeneca; 4m were Sinovac of China and 900,000 were Russia’s Sputnik V, coronavirus tsar Hugo López-Gatell told the news conference....
...Some of the demands on chemical companies’ resources comes from the need to plough investment into green technology....
...The aborted trials include Pfizer and Johnson & Johnson’s scrapped study in 2012 and Merck’s failed trial in 2017....
International Edition